1.
Pediatr Infect Dis J
; 40(12): e507-e509, 2021 12 01.
Article
in English
| MEDLINE | ID: covidwho-1625475
ABSTRACT
There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-19 who received monoclonal antibody therapy found that the treatment was well tolerated, safe, and may be effective in halting progression to severe disease.